After five years’ ownership in Mediplast AB, Priveq Investment divests the company to Addtech Holding, a company within the Addtech Group. RoosGruppen AB, the main owner of Mediplast, will remain minority owner together with the management of Mediplast and other companies within Addtech’s business Life Science.
Mediplast AB is the parent company of the Mediplast Group and is a leading Nordic supplier of medical technology equipment and consumables. The company has its head offices in Malmö and pursues operations via its own trading companies in Sweden, Denmark, Finland, Norway and the Netherlands. Mediplast also has its own production facilities in Denmark, Finland and Italy. The company holds a strong position in the Nordic countries and markets both its own products as well as those of leading suppliers in the areas of surgery, intensive care, thorax/neuro, ENT and ostomy care. Mediplast’s customers operate in both the private and public sectors. In the 2014 financial year, the Mediplast Group generated sales totalling approximately SEK 465 million, an operating profit before amortisation of intangible assets (EBITA) of around SEK 45 million and had roughly 120 employees. During the holding period, five acquisitions have been made and the company’s turnover has increased from about SEK 280 million at Priveq entry in 2010 to about SEK 500 million in 2015.
“During our ownership, we have completed several important acquisitions and established a number of pan-Nordic distribution rights for leading international product owners, which means that the company is stronger than ever. It feels very good that Mediplast now gets a new majority owner with the ambition to take the next step and continue to develop the company as an independent part of Addtech’s business Life Science” says Henrik Westfeldt, partner at Priveq Advisory AB, investment advisor to the Priveq funds.
“During the ownership of Priveq and RoosGruppen, Mediplast has grown both organically and through acquisitions. Thereby, Mediplast has strengthened its geographical presence and is now in an excellent position to continue growing as a part of a larger group” says Lars-Erik Rydell, CEO of the Mediplast Group.